•   Exclusive

A Textbook Transformation: How Biogen Idec Overhauled Its Supply Chain

The management team at Biogen Idec knew they had to transform the supply chain to cope with increasing volume and complexity at this biotech company. Beginning with a detailed gap analysis, they launched a comprehensive transformation program that addressed factors as varied as vendor continuity and purchase order processing times, drawing from sourcing best practices. The overhaul to date has proved to be a resounding success.

Subscriber: Log Out

Sorry, but your login has failed. Please recheck your login information and resubmit. If your subscription has expired, renew here.

This is an excerpt of the original article. It was written for the May-June 2011 edition of Supply Chain Management Review. The full article is available to current subscribers.

May-June 2011

People, process, technology. These are the three core elements that determine the relative success (or failure) of any organization. We’ve heard this in countless management books and keynotes speeches. And it’s hammered home in business school curricula across the country. Now it’s our turn. This issue of Supply Chain Management Review is devoted in roughly equal measures to the three core elements. Our rational: Their importance can never be stated enough.
Browse this issue archive.
Already a subscriber? Access full edition now.

Need Help?
Contact customer service
847-559-7581   More options
Not a subscriber? Start your magazine subscription.

Although strategic sourcing capabilities are well established in industries ranging from automotive to pharmaceuticals, they are still in the formative stages in the biotechnology sector.

It isn’t easy to drive the necessary changes. With their external spend increasing so fast, there is great pressure on biotech companies to rethink how their sourcing structures are set up to add most value. The first wave of strategic sourcing strategies is often targeted at cost-cutting through volume consolidation and leveraging of the organization’s total spend, followed by supplier base reduction and longer-term contracting. But as organizations mature, executives require their sourcing groups to develop and deliver additional capabilities. In a growing number of companies today, supply management is being asked to demonstrate deep insights into customer requirements, and to quickly translate those insights into product offerings that often rely more on outsourced capabilities.

Biogen Idec Inc. is showing how this can happen in the biotech sector. In the last year, the company has undergone a huge shift in the way it operates its supply chain, particularly in the management of sourcing.

This complete article is available to subscribers only.
Click on Log In Now at the top of this article for full access.
Or, Start your PLUS+ subscription for instant access.

Not ready to subscribe, but need this article?
Buy the complete article now. Only $20.00. Instant PDF Download
.
Access the complete issue of Supply Chain Management Review magazine featuring
this article including every word, chart and table exactly as it appeared in the magazine.

SC
MR

Sorry, but your login has failed. Please recheck your login information and resubmit. If your subscription has expired, renew here.

From the May-June 2011 edition of Supply Chain Management Review.

May-June 2011

People, process, technology. These are the three core elements that determine the relative success (or failure) of any organization. We’ve heard this in countless management books and keynotes speeches. And it’s…
Browse this issue archive.
Download a PDF file of the May-June 2011 issue.

Download Article PDF

Although strategic sourcing capabilities are well established in industries ranging from automotive to pharmaceuticals, they are still in the formative stages in the biotechnology sector.

It isn’t easy to drive the necessary changes. With their external spend increasing so fast, there is great pressure on biotech companies to rethink how their sourcing structures are set up to add most value. The first wave of strategic sourcing strategies is often targeted at cost-cutting through volume consolidation and leveraging of the organization’s total spend, followed by supplier base reduction and longer-term contracting. But as organizations mature, executives require their sourcing groups to develop and deliver additional capabilities. In a growing number of companies today, supply management is being asked to demonstrate deep insights into customer requirements, and to quickly translate those insights into product offerings that often rely more on outsourced capabilities.

Biogen Idec Inc. is showing how this can happen in the biotech sector. In the last year, the company has undergone a huge shift in the way it operates its supply chain, particularly in the management of sourcing.

SUBSCRIBERS: Click here to download PDF of the full article.

SC
MR

Latest Podcast
Talking Supply Chain: Doomsday never arrives for Baltimore bridge collapse impacts
The collapse of Baltimore’s Francis Scott Key bridge brought doomsday headlines for the supply chain. But the reality has been something less…
Listen in

Subscribe

Supply Chain Management Review delivers the best industry content.
Subscribe today and get full access to all of Supply Chain Management Review’s exclusive content, email newsletters, premium resources and in-depth, comprehensive feature articles written by the industry's top experts on the subjects that matter most to supply chain professionals.
×

Search

Search

Sourcing & Procurement

Inventory Management Risk Management Global Trade Ports & Shipping

Business Management

Supply Chain TMS WMS 3PL Government & Regulation Sustainability Finance

Software & Technology

Artificial Intelligence Automation Cloud IoT Robotics Software

The Academy

Executive Education Associations Institutions Universities & Colleges

Resources

Podcasts Webcasts Companies Visionaries White Papers Special Reports Premiums Magazine Archive

Subscribe

SCMR Magazine Newsletters Magazine Archives Customer Service